Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKesson
US Army
Merck
Cerilliant
Cantor Fitzgerald
Accenture
Julphar
UBS

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072078

« Back to Dashboard

NDA 072078 describes MECLOFENAMATE SODIUM, which is a drug marketed by Am Therap, Barr, Fosun Pharma, Mylan, Par Pharm, Usl Pharma, Vitarine, Watson Labs, and Watson Labs Teva, and is included in nineteen NDAs. It is available from one supplier. Additional details are available on the MECLOFENAMATE SODIUM profile page.

The generic ingredient in MECLOFENAMATE SODIUM is meclofenamate sodium. There are eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the meclofenamate sodium profile page.
Summary for 072078
Tradename:MECLOFENAMATE SODIUM
Applicant:Par Pharm
Ingredient:meclofenamate sodium
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrengthEQ 100MG BASE
Approval Date:Mar 10, 1988TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Cipla
Cantor Fitzgerald
Cerilliant
McKinsey
QuintilesIMS
US Army
Baxter
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.